Evidence map›Paper›PMID 33043453›Full record

SynthesisEuropean journal of clinical investigation2021

Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: A systematic review.

Michael Malaty, Tahrima Kayes, Anjalee T Amarasekera, Matthew Kodsi, C Raina MacIntyre, Timothy C Tan

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in European journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. COVID-19 and the cardiovascular system: an update.The American journal of the medical sciences · 2022
    Review
  10. Review
  11. Article
  12. COVID-19 and the CHAClinical medicine & research · 2021
    Article
  13. Review
  14. Article
  15. Contemporary approach to understand and manage COVID-19-related arrhythmia.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2021
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Michael MalatyDepartment of Cardiology, Blacktown Hospital, Sydney, NSW, Australia.ORCID https://orcid.org/0000-0001-6399-4282
Tahrima KayesDepartment of Cardiology, Blacktown Hospital, Sydney, NSW, Australia.
Anjalee T AmarasekeraSchool of Medicine, Western Sydney University, Sydney, NSW, Australia.
Matthew KodsiDepartment of Cardiology, Blacktown Hospital, Sydney, NSW, Australia.
C Raina MacIntyreFaculty of Medicine, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Timothy C TanDepartment of Cardiology, Blacktown Hospital, Sydney, NSW, Australia.ORCID https://orcid.org/0000-0003-4449-1457
Blacktown & Mount Druitt Hospital · AUUNSW Sydney · AUWestern Sydney University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide resulting in significant morbidity and mortality. Arrhythmias are prevalent and reportedly, the second most common complication. Several mechanistic pathways are proposed to explain the pro-arrhythmic effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. A number of treatment approaches have been trialled, each with its inherent unique challenges. This rapid systematic review aimed to examine the current incidence and available treatment of arrhythmias in COVID-19, as well as barriers to implementation.

methodsOur search of scientific databases identified relevant published studies from 1 January 2000 until 1 June 2020. We also searched Google Scholar for grey literature. We identified 1729 publications of which 1704 were excluded.

resultsThe incidence and nature of arrhythmias in the setting of COVID-19 were poorly documented across studies. The cumulative incidence of arrhythmia across studies of hospitalised patients was 6.9%. Drug-induced long QT syndrome secondary to antimalarial and antimicrobial therapy was a significant contributor to arrhythmia formation, with an incidence of 14.15%. Torsades de pointes (TdP) and sudden cardiac death (SCD) were reported. Treatment strategies aim to minimise this through risk stratification and regular monitoring of corrected QT interval (QTc).

conclusionPatients with SARS-CoV-2 are at an increased risk of arrhythmias. Drug therapy is pro-arrhythmogenic and may result in TdP and SCD in these patients. Risk assessment and regular QTc monitoring are imperative for safety during the treatment course. Further studies are needed to guide future decision-making.

Indexed as

Anti-Arrhythmia AgentsAnti-Bacterial AgentsAntimalarialsArrhythmias, CardiacAtrial FibrillationAtrial FlutterAzithromycinBradycardiaCardiac Pacing, ArtificialCOVID-19COVID-19 Drug TreatmentDeath, Sudden, CardiacElectric CountershockHospitalizationHumansHydroxychloroquineAnti-Arrhythmia AgentsAnti-Bacterial AgentsAntimalarialsAzithromycinHydroxychloroquinearrhythmiacoronavirusCOVID-19long QT syndromesudden cardiac death

Identifiers

PMID33043453
PMCPMC7646010
OpenAlexW3092004548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.